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Rabies is a viral zoonosis caused by negative-stranded RNA viruses of the Lyssavirus genus. It can affect all 
mammals including humans. Dogs are the main source of human rabies deaths, contributing up to 99% of all 
rabies transmissions to humans. Infection causes tens of thousands of deaths every year, mainly in Asia and 
Africa. Most of these victims are children under the age of 15. Vaccination against rabies is still the sole way to 
fight against the disease.  
 
The aim of this work is to compare the purity of rabies vaccine purified by zonal centrifugation and 
chromatographic methods, in terms of residual DNA level, host cell protein (HCP) level and the overall recovery 
yield. 
For this purpose, Vero cells were grown under animal component free conditions, on Cytodex 1 microcarriers in 
VP-SFM medium. Vero cell growth and virus production were previously optimized; studies were conducted in a 
7-L bioreactor. Virus replication phase was conducted using perfusion culture mode, viral harvests obtained 
through the culture were clarified, inactivated by BPL (Beta-propiolactone) and then pooled. 
 
The pooled harvests were purified by zonal centrifugation on a sucrose density gradient. The fractions of 
interest (11 in total) were pooled and checked for their antigenic activity according to the NIH potency test. They 
showed an activity of 61 UI/ml. The yield obtained was around 60%.  
 
To improve the overall yield, we have tested during a previous work several chromatography matrices 
(Sephacryl S200, Sephacryl S300, Sepharose 4FF,...). However the yield obtained was not high, around 40% in 
the best case. To improve this performance, we tested the Capto Core 700 (GE Healthcare Life Sciences) which 
a matrice that had a dual-functionality: size separation and binding chromatography, and was specially designed 
for the purification of large biological products such as viruses. The use of this matrice to purify rabies virus 
resulted in a yield of 84.5%, which was 2-fold and 1.5 fold higher than that obtained using chromatographic 
columns or zonal centrifugation, respectively. 
We also tested Monolytic chromatographic (CIMmultus™ QA-8 Advanced Composite Column) from BIA 
Separation. Such kind of media represents a new generation of chromatographic matrices with efficient mass 
transfer and better hydrodynamic properties. This allows fast and efficient separation of large molecules such as 
DNA and viruses. In our case, we were able to increase the purification yield to values close to 94%. It was the 
highest yield obtained compared to other methods used.  
 
Currently the content of the purified fractions collected using the different methods is analyzed to estimate the 
efficiency of DNA and HCP removal. 
 
